Delivery Order SPE2DB20D3505-SPE2DB25FV0A2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $10,997.42 and is a firm fixed-price delivery order with a completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The award, valued at $74,288.73, has a completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of VEMLIDY 25 MG TABLET UU 30S, a medical product, with a firm fixed price of $1,974.89 and a performance period through June 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VEMLIDY 25 MG TABLET in units of 30s, with a ceiling value of $2,370.92 and a period of performance through May 19, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $41,937.07 and a period of performance through June 26, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $2,809.67 and a performance period through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication VEMLIDY 25 MG TABLET UU 30S, with a ceiling value of $8,459.59 and a period of performance through June 24, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $3,835.32 and a period of performance through May 9, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there are no subcontractors mentioned. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET in 30-count packages. The $3,049.76 firm fixed-price contract has a completion date of September 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a comprehensive range of medical commodities to...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0A2Delivery Order
This is a firm fixed-price delivery order for the pharmaceutical product VEMLIDY 25 MG TABLET UU 30S, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,308.56 and a period of performance through July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This delivery order appears to be part of that larger IDC contract, which enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. There was no set-aside designation for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/16/25 |